Alzamend Neuro, Inc.
ALZN· Nasdaq
ALZNAlzamend Neuro, Inc.
Filed Sep 10, 2025 · 10-Q · 41 days after period end · 0001214659-25-013609
| Metric | Q1 2026 | Q1 2025 | Q1 2024 | Q1 2023 |
|---|---|---|---|---|
| Net Income | -$2.70M | -$974.41K | -$3.53M | -$3.04M |
| EPS Diluted | -$1.28 | -$1.25 | -$5.38 | -$0.03 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Alzamend Neuro, Inc. · CIK 1677077 · Engraved from SEC EDGAR
ended Jul 31, 2025 · filed Sep 10, 2025 · 41 d after period end
